Introduction
Untreated epilepsy is a major problem in poorer countries where about three quarters of people with active epilepsy are not on treatment [1] . Yet treatment with relatively inexpensive medication can abolish seizures in about two thirds of such patients [2] . There are a number or reasons for this treatment gap one of which is lack of access to doctors of any sort let alone neurologists [3, 4] -in many poorer countries most people live in the countryside whereas doctors usually live in cities.
Two broad solutions have been suggested to overcome this treatment gap: the first is to delegate functions of diagnosis and treatment to non-doctors such as nurses, paramedics or village health workers who are more numerous than doctors and who live closer to the people with untreated epilepsy [5, 6] . The second is to educate locally practising doctors and get them to take on a greater role in epilepsy care with support from specialists [7] . The exact operational details of these systems of care has not been fully documented but if either group is to take over a greater role in epilepsy care they will need some tools to help them. The World Health Organisation, as part of their Mental Health programme, have reviewed evidence on the specific question ''Can convulsive epilepsy be diagnosed at first level care by a non-specialist health care provider in low and middle income country settings?'' and concluded that there was a need for further studies to address this question [8].
Previously we have described a tool to enable non-doctors to diagnose episodes of altered consciousness as epileptic or not. This was developed in Nepal and was based on an analysis of the sort of questions which comprise routine history taking in this situation [9] . Questions with the highest likelihood ratios [10] of episodes being epileptic (E) or not epileptic (NE) were combined sequentially in the tool which then gave a post-test probability score of a particular episode being E. This mimics the way experienced Untreated epilepsy Epilepsy treatment gap Phone app mHealth Health workers Bayesian A B S T R A C T Purpose: Untreated epilepsy is a major global public health problem with more than 20 million people not being treated for an easily treatable disease. In part this is due to a lack of trained doctors. There are many more non-medical health workers than doctors and they could have an important role in diagnosis and treatment of epilepsy if they had some tools. We have previously described such a tool to distinguish epileptic episodes from other causes of altered consciousness and here present its validation in three new populations. Methods: The tool was presented as a phone app where the answers to 11 questions provided a probability score which indicated whether episodes might be due to epilepsy or not. It was applied either by non-medical volunteers, health workers, or inexperienced doctors to 132 patients in three separate populations in India and Nepal and compared with the ''gold standard'' diagnosis of a neurologist with expertise in epilepsy. Results: There was good agreement between the app score and the neurologists' diagnoses (weighted kappa = 75.3%). An app score of 90 or greater had a sensitivity of 88% and a specificity of 100% for diagnosing epilepsy. The app was easy to use with little training and took about 5 min to administer. Conclusion: A tool presented as a phone app can be used by non-medical health workers to identify episodes as epileptic or not with good accuracy. It needs to be evaluated more widely but has the potential to play a part in reducing the epilepsy treatment gap.
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doctors make the diagnosis. That tool showed initial promise in separating E from NE in a small population of 14 patients. The aim of the present study is to test its validity in a larger series of patients from India and Nepal.
Methods

Locations
Patients were studied at three separate locations. These were all special clinics for people with suspected epilepsy which had been advertised as widely as possible during the preceding weeks using local notices, newspapers, local radio and word-of-mouth. Patients were assessed clinically, in the usual way, by the authors shown in parentheses. The patients were all new attendances to the authors.
1. An epilepsy clinic on the Lifeline Express Hospital train based at Raipur India (MS). 2. Epilepsy camps at Dhulikhel Hospital Nepal (VP). 3. Epilepsy camps run by the Nepal Epilepsy Association at three places in Western Nepal (HR, VP).
Use of the diagnostic tool
The previously described tool was incorporated into a phone app to run on Android TM phones. This app was developed by
NetProphets Cyberworks Pvt Ltd. Each record consisted of an identifying clinic number and the 11 questions which had been defined in the previous study. These are shown in Table 1 with the available answers.
Using the same algorithm as in the previous study a probability score for the episode being epileptic was then calculated. The pretest probability of having epilepsy from the original study -0.76 -was used giving pre-test odds of 3-1 in favour of having epilepsy. The odds were then multiplied by the likelihood ratio for having epilepsy of each of the 11 questions inputted sequentially. This final figure was then converted to a probability score which was displayed on the phone screen. The records were stored on the mobile phone and later uploaded to a secure server from which they could then be downloaded for analysis as a .csv file. No patient-identifiable information was stored on either the individual phone or on the server. The record was linked by a study number to the patient record which avoided duplicate entries.
The tool was used by non-doctors in location 1, by trainee doctors in location 3, and by a combination of the two in location 2. The health workers and trainee doctors were trained in using the phone app by being taken through it once by VP and being given a three-page set of guidelines. VP was available to answer specific questions if required. The average time to use the phone app was recorded on a sample of the patients at location 1.
At location 1 the tool was used in a separate session either before or after the clinical consultation. The order was predetermined by randomizing study numbers to being assessed either before or after the clinical consultation. At locations 2 and 3 the tool was used in the course of the clinical consultation. The trainee doctor or health worker who entered the data also acted as translator for VP.
Clinical assessment
Only patients with episodes of loss of consciousness or awareness over nine years of age were included. Patients were seen by a neurologist and their episodes were categorized as epileptic (E), not epileptic (NE) or uncertain (U). This was done in the usual way based on a history from the patient and from an available eyewitness, obtained in person or by phone, followed by an examination of the patient. The neurologists came to their conclusion without reference to the phone app score.
Ethics
The study was approved by the Ethics Committee of the All India Institute of Medical Sciences.
Results
Patients seen
Details are shown in Table 2 . The final diagnoses in those who did not have epilepsy included a single case of parasomnia with the rest being either non-epileptic attacks or panic attacks. There were no cases of syncope. At Raipur it proved impossible to randomize patients into being tested before or after their clinical consultation as in practice they tended to disappear after their consultations with the doctor and then the epilepsy educators. So in practice most app testing was carried out before the clinical consultation.
Probability scores
The probability scores as determined by the phone app are shown in Fig. 1 for each patient in each of the three clinical groups displayed in ascending order of probability score -E, NE and U. In general there is near-complete separation between the groups. Three patients who were clinically uncertain achieved very low probability scores using the app because there was no eyewitness available to give an account of the seizure. In future the absence of an eye-witness combined with a low probability score will categorize the patient as uncertain. In general, those patients whom the app categorized as uncertain had less well-described seizures with more ''not known'' answers to the questions posed by the app. The data in shown in tabular form in Table 3 with the mean and median probability score for each of the three clinical groups.
Measure of agreement
From Fig. 1 and Table 3 , an app probability score of >90 can be taken to indicate probable epilepsy and an app score <30 probable non-epilepsy with the remaining 13% being uncertain. This would have sensitivities and specificities respectively for epilepsy of 88% (95% Confidence Interval [CI]: 80.6%, 93.6%) and 100% (95% CI: 75.3%, 100%) and for not epilepsy of 100% and 72%. Table 4 shows the agreement between the clinician and the app for these three diagnoses using this paradigm. The weighted kappa scores indicate a ''good'' level of agreement.
An alternative paradigm where the app probability score for epilepsy was >80 would be relevant to 90% of the population and increase the sensitivity for the diagnosis of epilepsy to 92% without affecting the other sensitivities and specificities above.
Ease of use
Health workers and trainee doctors reported no significant difficulties in using the mobile phone app. Minimal input from VP was required. The average time to complete the app questions was 5 min.
Discussion
This phone app is effective in diagnosing epileptic and nonepileptic seizures in the two Nepalese and one Indian populations in which it was studied. This confirms the promise shown in its development and early validation phases [9] . It clearly separates the three different clinical diagnoses -epilepsy, not epilepsy and uncertain. Even with very conservative limits for diagnosis, it is applicable to over 85% of presenting patients, its sensitivity and specificity for both epileptic and non-epileptic attacks are high and it compares well with clinical diagnosis when measured by the kappa statistic. In practice it was easy for non-doctors to use with very little instruction and took only about 5 min to administer.
This validation study was carried out in three different ''reallife'' settings in over 100 patients and using a mixture of volunteers, health workers and inexperienced doctors to administer the app. Three different neurologists provided the ''gold standard'' clinical diagnosis compared to single neurologist in the early validation study. The three settings provided different percentages of patients who had epilepsy -100% in Raipur, 56% at Dhulikhel and 79% in Western Nepal. There are many possible explanations for this difference including variations in how the clinic announcements were made and interpreted in local languages, and how nonepilepsy patients were recorded. One part of the algorithm used by the app is pre-test probability of 0.76 for someone having epilepsy, this figure being derived from a study in Nepal. Whether this is important in populations where the pre-test probability may be higher or lower should be evident from studies in different populations such as the present one. If pre-test probability is indeed 100% then of course there is no need for an app.
Presenting the tool as a phone app has a number of distinct advantages: first people are more likely to have a mobile phone than a laptop or a programmable calculator. Second it is easier to enter the data than, for example, using paper. Third it is easy to aggregate and analyze results by uploading the data to a webserver when back in an area where there is a wireless Internet connection. Fourth it is easy to update and improve the tool; for example in this study we showed that if there is no eye witness available then diagnoses of non-epileptic episodes were made by the app when the correct clinical diagnosis was uncertain; it is easy to provide an update to the app which includes a rule that, if no eye witness is available and the probability score is less than 30, then the episode should be regarded as uncertain. Indeed this has already been done. Also the score above which epilepsy was regarded as probable was set at 90 prior to the study. The results show that the sensitivity could be increased by recalibrating this to 80 without any loss of specificity. Fig. 1 . Probability scores for 132 individual patients by type of clinical diagnosis displayed in ascending order of probability score. This app was tested in real-life situations rather than a carefully-controlled clinic setting so it was not possible to eliminate a number of sources of potential bias such as whether patients already on treatment for epilepsy might react differently to untreated patients and whether the order of testing before or after the clinical consultation might be relevant and whether subtle cues from the translator might have altered the outcome. Also it could be argued that not all health workers will have smartphones. This may well be the case at present but statistics on mobile phone usage from resource-poor countries suggests an exponential growth of smartphone usage [11] so it is unlikely to be the case in a few years time.
No diagnostic tool is ever going to be 100% accurate in diagnosing an episode of altered consciousness as epileptic. The levels of agreement between the tool and the neurologists in this study are however very much better than published interphysician agreement from the UK in the 1990s where misdiagnosis rates of 20-30% were found in those attending a specialist epilepsy service [12] . Details of the misdiagnosis rate in primary care in poorer countries are more difficult to come by.
Another potential use of this tool is in screening populations for epilepsy in door-to-door surveys. The present methods of doing this involve screening questionnaires such as those reviewed by the World Health Organisation (WHO) [8] . The sensitivity and specificity of this tool is as good as any of those described and compares well with the sensitivity of 72% and specificity of 100% in a study from Asia [13] . Again the availability of a tool as a phone app makes data collection and interrogation much simpler. However this app has a narrow footprint, having been tested only in areas of Nepal and India and needs to be tested in other poorer countries. The app is also unlikely to be reliable in epilepsy populations in richer countries which will have very different clinical characteristics. This is the case in a tertiary referral centre in Scotland (Dr. Aline Russell, personal communication).
Conclusion
This tool is only one piece of the jigsaw in delivering treatment to the 20 million people with epilepsy who are presently untreated. And diagnosing an episode as epileptic is only one step in determining whether treatment is required and if so which treatment. The app [14] now needs to be used and tested in wider areas to see if it can fulfil its early promise and other medical pieces of the jigsaw, such as frequency and provocation of episodes, now need to be addressed in a similar fashion. Untreated epilepsy is mostly a public health problem but it has some important medical aspects. When these can be devolved safely to non-doctors then dealing with the public health problem will be much easier.
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